By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Generex Biotechnology Corporation (GNBT) Announces Publication Of AE37 Prostate Cancer Vaccine Study 8/6/2014 8:45:03 AM
Generex Biotechnology Corporation (GNBT) Announces Interview Of Dr. Eric Von Hofe, President Of Antigen Express, Inc. (GNBT), Following Recent Keynote Presentation 6/17/2014 10:27:43 AM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/13/2014 12:45:03 PM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/12/2014 8:21:57 AM
Generex Biotechnology Corporation (GNBT) / Antigen Express, Inc. (GNBT) To Participate In 2014 Biotechnology Industry Organization (BIO) International Convention 6/10/2014 7:49:21 AM
Generex Biotechnology Corporation (GNBT) Announces Presentation Of Primary Efficacy Data & Immunological Response From The Phase II Study Of AE37 Cancer Vaccine At American Society of Clinical Oncology 5/20/2014 8:32:15 AM
Generex Biotechnology Corporation (GNBT) Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations At American Society of Clinical Oncology 2014 Annual Meeting 4/23/2014 7:48:40 AM
Generex Biotechnology Corporation (GNBT) Announces $2,075,000 Capital Investment 3/27/2014 9:30:29 AM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announces Participation On Panel At Upcoming Cancer Immunotherapeutics Symposium 3/26/2014 7:44:03 AM
Generex Biotechnology Corporation (GNBT) Subsidiary Antigen Express Receives Patents For Vaccines Targeting HPV Induced Cancers And Influenza 3/5/2014 10:42:12 AM
12345678910...
//-->